Search

everythinglearnresearchcommunity

for

Search:↓

The fish oil-based gel with imiquimod improves skin cancer treatment and reduces inflammation.

A protein called lfTSLP is important in causing allergic and other skin diseases and could be a target for treatment.

Runx1 affects hair growth, cancer development, and autoimmune diseases in epithelial tissues.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

Certain immune-related proteins are higher in people with alopecia and their healthy relatives, hinting at a genetic link.

Long-haul COVID can cause lasting symptoms affecting many body systems and may be linked to ongoing inflammation and immune system issues.

Type I interferons play a key role in the development of various skin diseases.

Finasteride causes reduced tear flow and severe eye inflammation.

Fat cells in the skin help start healing and form important repair cells after injury.

A mother's PPARγ is crucial for preventing harmful milk that can cause inflammation and growth problems in babies.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

CRAC channels are crucial for the development and function of specialized immune cells, preventing severe inflammation and autoimmune diseases.

Small molecule DMF improves psoriasis and multiple sclerosis, adult skin cells can be made to grow new hair, certain skin cells initiate hair growth, IL-17C controls gut health and can cause skin inflammation, and skin cells produce IL-17 that can lead to psoriasis.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

Dupilumab may cause significant hair loss, which can reverse after stopping the drug.

Hormones and neuroendocrine factors control hair growth and color, and more research could lead to new hair treatment options.

Silver nanoparticles in gel form can effectively heal wounds.

Targeting CD200 could be a new treatment for rheumatoid arthritis.

The document concludes that freeze-dried platelet-rich plasma shows promise for medical use but requires standardization and further research.

Apremilast did not work for treating severe alopecia areata.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Blocking IL-12/IL-23 does not help with hair loss in alopecia areata for mice or humans.

STAT3 signaling is important for healthy skin and hair follicles, and its disruption can lead to skin conditions like atopic dermatitis.

Researchers identified genes and proteins that may influence wool thickness in sheep.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.